View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
May 2, 2011

D Medical Subsidiary Receives FDA Approval to Market its Insulin Pump

D Medical Industries subsidiary Spring-Set Health Solutions has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its Spring Universal Infusion Sets in the US. The Spring Universal is a semi-disposable insulin pump that continuously infuses insulin into

By cms admin

D Medical Industries subsidiary Spring-Set Health Solutions has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its Spring Universal Infusion Sets in the US.

The Spring Universal is a semi-disposable insulin pump that continuously infuses insulin into a patient’s body, using its proprietary spring-based delivery technology and is cost-effective compared to motor and gear train mechanisms.

At its core is the proprietary detach-detect mechanism, which triggers a blocking mechanism that creates an occlusion when the base of the infusion set detaches from the user’s body.

This further evokes an occlusion alarm in the insulin pump enabling continuously controlled and monitored insulin delivery, providing additional safety.

The Spring Universal Infusion Set also reduces pain and discomfort, and offers enhanced insertion stability.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management